Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

Chi Young Shim, Jiwon Seo, Iksung Cho, Chan Joo Lee, In Jeong Cho, Purevjargal Lhagvasuren, Seok Min Kang, Jong Won Ha, Gyoonhee Han, Yangsoo Jang, Geu Ru Hong

Research output: Contribution to journalArticlepeer-review

49 Scopus citations
Original languageEnglish
Pages (from-to)510-512
Number of pages3
Issue number5
StatePublished - 2 Feb 2021

Bibliographical note

Funding Information:
The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).


  • diabetes mellitus
  • diastole
  • echocardiography, stress
  • function
  • sodium-glucose transporter 2 inhibitors

Cite this